Chronic Obstructive Pulmonary Disease (COPD) and emphysema are debilitating conditions that can make even simple tasks like walking or climbing stairs feel insurmountable. For many in the Texas ...

Approval of First Minimally Invasive Treatment Option in Japan that Helps Patients with Advanced Disease Breathe Easier and Have a Better Quality of Life Over 600,000 Japanese patients suffer from ...

The Zephyr Endobronchial Valve has been given market approval by the Food and Drug Administration. The treatment is for those with severe emphysema, which is a type of chronic obstructive pulmonary ...

CINCINNATI (WXIX) - Monday is World Lung Day, a day to spread awareness about lung diseases, and one patient is opening up about a new procedure that saved his life. Rick Scroggins is a patient at The ...

The Zephyr Valve Helps COPD/Emphysema Patients Breathe Easier Without the Risk of Major Surgery 1 REDWOOD CITY, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- As part of COPD Awareness Month, Pulmonx ...

REDWOOD CITY, Calif.--(BUSINESS WIRE)--Pulmonx Corporation announced today that the French Health Ministry has granted national reimbursement for the Zephyr Endobronchial Valve, the first ...

CHILLICOTHE— A new, minimally invasive procedure now being offered by Adena Health System for patients suffering from emphysema and COPD. “We’ve actually been talking about doing this type of ...

SCHENECTADY – Thomas Murphy of Fulton County had a new Zephyr valve procedure in March. "I couldn’t walk 30 feet before the procedure," he said. Now, he has something back. "Freedom!" Murphy said. "I ...

“I am pleased with our team’s continued execution across several key commercial and clinical initiatives designed to increase patient access to our life changing Zephyr Valve treatment,” said Steve ...

Pulmonx Corporation's shares have performed poorly over the past year, returning -16%. The company's CEO recently announced his retirement, raising questions about potential changes in corporate ...

REDWOOD CITY, Calif. & TOKYO--(BUSINESS WIRE)--Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx”), a global leader in minimally invasive treatments for severe lung disease, announced today that the ...